| Literature DB >> 34072696 |
Sabry M El-Bahr1,2, Amal M Elbakery3, Nashwa El-Gazzar4, Aziza A Amin5, Saad Al-Sultan6, Mohamed A Alfattah7, Saad Shousha1,8, Sameer Alhojaily1, Mohammad Shathele9, Islam I Sabeq10, Ahlam F Hamouda11.
Abstract
This study aimed to investigate the ameliorative effects of iron oxide nanoparticles (IONPs) prepared from leaf extract of Petroselinum crispum compared to those prepared using a chemical method in lead-acetate-induced anemic rats. Twenty rats were divided into four groups (five rats each). Throughout the experimental period (8 weeks), the rats in group 1 were not given any therapy. The rats in groups 2, 3 and 4 were given 400 ppm lead acetate orally for 2 weeks to make them anemic. Following that, these rats were either left untreated, given 27 ppm of chemical IONPs orally or given 27 ppm of natural IONPs orally for the remaining 6 weeks of the experiment. TEM analysis indicated that the chemically and naturally prepared IONPs had sizes of 6.22-9.7 and 64-68 nm, respectively. Serum ferritin and iron concentrations were reduced, whereas the total iron-binding capacity (TIBC), ALT, AST, urea and creatinine were significantly increased in the non-treated lead-acetate-induced anemic rats compared to those of the control. In addition, congestion, hemorrhage, necrosis, vacuolation and leukocytic infiltration in the kidneys, liver and spleen were observed in non-treated lead-acetate-induced anemic rats compared to the control. The effects of lead acetate were mitigated by IONPs, particularly the natural one. In conclusion, IONPs produced from Petroselinum crispum leaf extract can be used as an efficient and safe therapy in lead-acetate-induced anemic rats.Entities:
Keywords: Petroselinum crispum; anemia; lead acetate; nanoparticles; rats
Year: 2021 PMID: 34072696 PMCID: PMC8227184 DOI: 10.3390/toxics9060123
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1The magnetic property of IONPs prepared using chemical method (A) and Petroselinum crispum leaf extract (B). Values are expressed as mean ± standard deviation (SD; n = 10).
Figure 2TEMs image of iron oxide nanoparticles biosynthesized using (A) chemical method and (B) green biosynthesis method with Petroselinum crispum leaf extract. Values are expressed as mean ± standard deviation (SD; n = 5). Data provided by statistical computer system of TEM.
Figure 3Size distributions of IONPs synthesized chemically (A) or using Petroselinum crispum leaf extract (B) in colloids. Size distribution of the particles was estimated from laser particle analyzer (LPA) images by measurement of diameters provided by the computer programming system of Zetasizer (Nano ZS, Malvern, UK).
Iron profile in lead-acetate-induced anemic rats treated with chemical or green biosynthesized magnetic iron oxide nanoparticles.
| Groups | Ferritin (ng/dL) | Iron (µg/dL) | TIBC (mcg/dL) |
|---|---|---|---|
| 1 | 0.70 ± 1.5 a | 2.31 ± 1.8 a | 6.01 ± 1.4 b |
| 2 | 0.47 ± 0.2 b | 1.29 ± 0.1 c | 8.53 ± 0.2 a |
| 3 | 0.50 ± 0.1 b | 1.89 ± 0.4 b | 6.26 ± 0.7 b |
| 4 | 0.70 ± 0.3 a | 1.64 ± 0.2 b | 6.96 ± 0.3 b |
Values are expressed as mean ± standard deviation (SD) of five rats for each group. a–d Means with different superscripts in the same column differ significantly at p < 0.05. Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment. TIBC: Total iron-binding capacity.
Hematological indices in lead-acetate-induced anemic rats treated with chemical or green biosynthesized magnetic iron oxide nanoparticles.
| Groups | Hb (mg/dl) | RBCs (×10⁶ µL) | PCV (%) | MCV (fl/cell) | MCH (pg/cell) | MCHC (g/dL) |
|---|---|---|---|---|---|---|
| 1 | 13.8 ± 2.7 a | 6.07 ± 1.6 ab | 36.6 ± 5.5 a | 60.5 ± 3.5 a | 20.43 ± 1.2 a | 33.9 ± 3.1 a |
| 2 | 8.73 ± 2.36 c | 5.48 ± 1.2 c | 28.3 ± 3.4 b | 51.7 ± 1.6 b | 19.07 ± 1.5 b | 30.7 ± 1.5 b |
| 3 | 11.7 ± 1.3 b | 6.09 ± 1.7 ab | 36.83 ± 1.8 a | 60.8 ± 1.5 a | 20.8 ± 1.0 a | 32.67 ± 1.3 a |
| 4 | 12.66 ± 2.5 a | 6.57 ± 1.5 a | 39.53 ± 2.0 a | 60.13 ± 2.8 a | 20.73 ± 1.1 a | 32.5 ± 0.3 a |
Values are expressed as mean ± standard error of means (SD) of five rats for each group. a–d Means with different superscripts in the same column differ significantly at p < 0.05. Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment.
Liver and kidney function in lead-acetate-induced anemic rats treated with chemical or green biosynthesized magnetic iron oxide nanoparticles.
| Groups | Urea (mg/dL) | Creatinine (mg/dL) | AST (U/mL) | ALT (U/mL) |
|---|---|---|---|---|
| 1 | 24.89 ± 4.4 d | 0.71 ± 0.1 c | 64.1 ± 6.1 d | 27.9 ± 3.4 d |
| 2 | 125.87 ± 5.1 a | 3.21 ± 0.9 a | 145.7 ± 6.4 a | 60.00 ± 1.7 a |
| 3 | 55.50 ± 3.3 b | 1.61 ± 0.3 b | 111.9 ± 8.8 b | 44.67 ± 3.1 b |
| 4 | 42.98 ± 6.1 c | 0.97 ± 0.3 c | 84.62 ± 9.1 c | 37.34 ± 3.0 c |
Values are expressed as mean ± standard deviation (SD) of five rats for each group. a–d Means with different superscripts in the same column differ significantly at p < 0.05. Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment.
Figure 4Histopathological features of kidneys in lead-acetate-induced anemic rats (a–d) treated with 27 ppm/day iron oxide nanoparticles (e) prepared chemically or (f) green biosynthesized with Petroselinum crispum leaf extract for 6 weeks. (a) Thrombosis of the renal blood vessels (T letter) with degenerative changes of the lining epithelium of the convoluted tubules (arrow). (b) Necrosis and atrophy of the glomerular tuft (N letter) with extensive hydropic degeneration of the lining epithelium of some renal tubules (D letter) and its necrosis with pyknotic nuclei in other tubules (arrow). (c) Inter-tubular mononuclear leukocytic cellular infiltration, mainly lymphocytes (arrow). (d) Precipitation of lead pigment either in the lining epithelium of the convoluted tubules or in the lumen of renal tubules (arrow ×1000). (e) Vacuolation of the lining epithelium of some renal tubules (arrow) and (f) fibrous connective tissue proliferation around the degenerated renal tubules (arrow).
Figure 5Histopathological features of liver in lead-acetate-induced anemic rats (a–c) treated with 27 ppm/day iron oxide nanoparticles (d,e) prepared chemically or (f) green biosynthesized with Petroselinum crispum leaf extract for 6 weeks. (a) Congestion of the portal veins with mild hyperplasia of the biliary epithelium (arrow). (b) Focal area of lytic necrosis characterized by loss of hepatocytes and replaced by aggregates of mononuclear leukocytes (arrow). (c) Apoptotic bodies in some degenerated hepatocytes (arrow, ×1000). (d) Degenerative changes of hepatocytes in combination with fibrous connective tissue proliferation around the bile duct (arrow). (e) Portal areas were mildly expanded by aggregates of mononuclear inflammatory cells—mainly lymphocytes and macrophages—in association with mild hyperplasia of the lining epithelium of the bile duct. (f) Improvement in the hepatocellular architecture with more regular and less altered hepatocytes.
Effect of chemical and natural iron oxide nanoparticles on the pathological grading of lead toxicity in renal tissues of different treated groups.
| Groups | Number | Pathological Grading | |||
|---|---|---|---|---|---|
| 0 | I | II | III | ||
| 1 | 5 | 5 | 0 | 0 | 0 |
| 2 | 5 | 0 | 1 | 1 | 3 |
| 3 | 5 | 0 | 1 | 3 | 1 |
| 4 | 5 | 3 | 1 | 1 | 0 |
Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment.
Effect of chemical and natural iron oxide nanoparticles on the pathological grading of lead toxicity in hepatic tissue of different treated groups.
| Groups | Number | Pathological Grading | |||
|---|---|---|---|---|---|
| 0 | I | II | III | ||
| 1 | 5 | 5 | 0 | 0 | 0 |
| 2 | 5 | 0 | 1 | 1 | 3 |
| 3 | 5 | 0 | 2 | 3 | 0 |
| 4 | 5 | 2 | 2 | 1 | 0 |
Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment.
Figure 6Histopathological features of spleen in lead-acetate-induced anemic rats (a,b) treated with 27 ppm/day iron oxide nanoparticles (c) prepared chemically or (d) green biosynthesized with Petroselinum crispum leaf extract for 6 weeks. (a) Extensive diffuse areas of hemorrhages in the red pulp. (b) Lymphoid depletion of the white pulp. (c) Mild lymphoid depletion of the white pulp. (d) Mild congestion of blood vessels of red pulp and normal lymphoid follicles of white pulp.
Effect of chemical and natural iron oxide nanoparticles on the pathological grading of lead toxicity in splenic tissue of different treated groups.
| Groups | Number | Pathological Grading | |||
|---|---|---|---|---|---|
| 0 | I | II | III | ||
| 1 | 5 | 5 | 0 | 0 | 0 |
| 2 | 5 | 0 | 1 | 2 | 2 |
| 3 | 5 | 0 | 2 | 3 | 0 |
| 4 | 5 | 3 | 1 | 1 | 0 |
Group 1: Rats administered distilled water orally throughout the experimental period without any treatment (negative control). Group 2: Non-treated lead-acetate-induced anemic rats (positive control). Group 3: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of chemically prepared iron oxide nanoparticles until the end of the experiment. Group 4: Lead-acetate-induced anemic rats treated with daily oral administration of 27 ppm of plant iron oxide nanoparticles prepared from Petroselinum crispum leaf extract until the end of the experiment.